Page last updated: 2024-09-03

calpain inhibitor 2 and Colonic Neoplasms

calpain inhibitor 2 has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertino, P; Hara, JH; Hashimoto, AS; Hoffmann, FW; Hoffmann, PR; Huang, Z; Mafnas, C; Rose, AH	1

Other Studies

1 other study(ies) available for calpain inhibitor 2 and Colonic Neoplasms

Article	Year
Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer. Inflammatory bowel diseases, 2015, Volume: 21, Issue:9 Topics: Animals; Azoxymethane; Cell Proliferation; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Injections, Intraperitoneal; Macrophage Activation; Mice; NF-kappa B; Oligopeptides; Translocation, Genetic	2015

Article

Year

Calpain-2 Inhibitor Therapy Reduces Murine Colitis and Colitis-associated Cancer.

Inflammatory bowel diseases, 2015, Volume: 21, Issue:9

Topics: Animals; Azoxymethane; Cell Proliferation; Colitis; Colonic Neoplasms; Cytokines; Dextran Sulfate; Disease Models, Animal; HT29 Cells; Humans; I-kappa B Proteins; Inflammation; Injections, Intraperitoneal; Macrophage Activation; Mice; NF-kappa B; Oligopeptides; Translocation, Genetic

2015